Results 71 to 80 of about 609,595 (394)

Cervical cancer: Epidemiology, risk factors and screening

open access: yesChinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2020
Cervical cancer is one of the leading causes of cancer death among females worldwide and its behavior epidemiologically likes a venereal disease of low infectiousness.
Shaokai Zhang   +3 more
semanticscholar   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Effectiveness of opportunistic screening for cancer of the cervix uteri [PDF]

open access: yes, 2006
The incidence and mortality of uterine cervical cancer in the Maltese Islands has remained relatively constant in medical records of the last few decades.
Busuttil, Roderick   +2 more
core  

Health-care providers' perceptions, attitudes towards and recommendation practice of cervical cancer screening [PDF]

open access: yes, 2016
In Libya, cervical cancer is ranked third as the most frequent cancer among women with early diagnosis being shown to reduce morbidity and mortality. Health-care providers can influence women's screening behaviours, and their lack of recommendations for ...
Hweissa, N.Ab.   +2 more
core   +1 more source

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

open access: yesJournal of the American Medical Association (JAMA), 2018
Importance The number of deaths from cervical cancer in the United States has decreased substantially since the implementation of widespread cervical cancer screening and has declined from 2.8 to 2.3 deaths per 100 000 women from 2000 to 2015.
US Preventive Services Task Force   +17 more
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Prevention of Cervical Cancer Among Mother in YOGYAKARTA, Indonesia [PDF]

open access: yes, 2018
Cervical cancer was one of the global commitments in Sustainable Development Goals (SDGs). Cervical cancer represents 7.5% of all deaths caused by cancer in women.
Meilani, N. (Niken)   +1 more
core   +3 more sources

International Anal Neoplasia Society's consensus guidelines for anal cancer screening

open access: yesInternational Journal of Cancer
The International Anal Neoplasia Society (IANS) developed consensus guidelines to inform anal cancer screening use among various high‐risk groups. Anal cancer incidence estimates by age among risk groups provided the basis to identify risk thresholds to ...
Elizabeth A. Stier   +18 more
semanticscholar   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

open access: yesMolecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study

open access: yesMicrobiology Spectrum
The use of clinically validated human papillomavirus (HPV) assays is recommended in cervical cancer screening, and extended genotyping is getting attention as a triage biomarker because of the different oncogenic risk of the high-risk HPV genotypes.
Laura De Marco   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy